Pal T - Search Results

1

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R. Pal T, et al. Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991 Free article.

2

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Thiffault I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, Cowie S, Deschênes J, Meschino W, Odefrey F, Goldgar D, Graham T, Narod S, Watters AK, MacNamara E, Du Sart D, Chong G, Foulkes WD. Thiffault I, et al. Among authors: pal t. Br J Cancer. 2004 Jan 26;90(2):483-91. doi: 10.1038/sj.bjc.6601424. Br J Cancer. 2004. PMID: 14735197 Free PMC article.

3

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

Pal T, Sutphen R, Sellers T. Pal T, et al. Cancer. 2004 Jun 1;100(11):2485-6; author reply 2486. doi: 10.1002/cncr.20247. Cancer. 2004. PMID: 15160358 Free article. No abstract available.

4

BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.

Pal T, Permuth-Wey J, Holtje T, Sutphen R. Pal T, et al. Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1794-9. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15533909

5

Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.

Sellers TA, Schildkraut JM, Pankratz VS, Vierkant RA, Fredericksen ZS, Olson JE, Cunningham J, Taylor W, Liebow M, McPherson C, Hartmann LC, Pal T, Adjei AA. Sellers TA, et al. Among authors: pal t. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2536-43. doi: 10.1158/1055-9965.EPI-05-0142. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16284375

6

Improved survival in BRCA2 carriers with ovarian cancer.

Pal T, Permuth-Wey J, Kapoor R, Cantor A, Sutphen R. Pal T, et al. Fam Cancer. 2007;6(1):113-9. doi: 10.1007/s10689-006-9112-x. Fam Cancer. 2007. PMID: 17160431 Free PMC article.

7

The presence of germ line mosaicism in cleidocranial dysplasia.

Pal T, Napierala D, Becker TA, Loscalzo M, Baldridge D, Lee B, Sutphen R. Pal T, et al. Clin Genet. 2007 Jun;71(6):589-91. doi: 10.1111/j.1399-0004.2007.00812.x. Clin Genet. 2007. PMID: 17539909

8

A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.

Pal T, Permuth-Wey J, Sellers TA. Pal T, et al. Cancer. 2008 Aug 15;113(4):733-42. doi: 10.1002/cncr.23601. Cancer. 2008. PMID: 18543306 Free PMC article. Review.

9

BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.

Pal T, Vadaparampil S, Betts J, Miree C, Li S, Narod SA. Pal T, et al. Genet Test. 2008 Sep;12(3):401-7. doi: 10.1089/gte.2007.0108. Genet Test. 2008. PMID: 18752448

10

Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Pal T, Permuth-Wey J, Kumar A, Sellers TA. Pal T, et al. Clin Cancer Res. 2008 Nov 1;14(21):6847-54. doi: 10.1158/1078-0432.CCR-08-1387. Clin Cancer Res. 2008. PMID: 18980979 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

714 results

Search Page

Filters